ZURICH/BERLIN, Sept 14 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
NOVARTIS NOVN.S
A federal judge on Tuesday dismissed, for the second time, a
whistleblower lawsuit accusing drugmaker Novartis AG of paying
kickbacks to doctors through a sham speaker program to promote
its multiple sclerosis drug Gilenya urn:newsml:reuters.com:*:nL1N30K2JK
COMPANY STATEMENTS
* Lalique Group SA LLQ.S : H1 net profit 4.6 mln EUR vs 3.1
mln yr ago LLQ.S
ANNUAL GENERAL MEETINGS
Logitech International SA LOGN.S - 0.96 eur/shr dividend
proposed
ANALYSTS' VIEWS
ROCHE HOLDING AG ROG.S : BERENBERG RAISES TO BUY FROM HOLD;
RAISES TARGET PRICE TO CHF 380 FROM CHF 350
NOVARTIS AG NOVN.S : BERENBERG CUTS TO HOLD FROM BUY; CUTS
TARGET PRICE TO CHF 80 FROM CHF 90
UBS GROUP AG UBSG.S : CREDIT SUISSE RAISES TARGET PRICE TO
CHF 22.5 FROM CHF 22
GIVAUDAN SA GIVN.S : JEFFERIES CUTS TARGET PRICE TO CHF
2600 FROM CHF 3000
ECONOMY
No major Swiss economic data scheduled
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))